LOUIS G LANGE
CIK 1238401 · EVP Cardiovascular Therapeutic · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$839.9K
Companies
6
Total Filings
70
Lifetime Open-Market Net
-$20.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAMSW | Director | 10,360 | $18.80 | $194.8K | -$2.09M | 10 | 2026-03-12 |
| BOLD | Director | 0 | $1.41 | $0 | -$9.35M | 19 | 2020-01-15 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 2 | 2015-06-30 |
| ESPR | Director | 204,803 | $3.15 | $645.1K | $199.0K | 1 | 2013-07-01 |
| GILD | EVP Cardiovascular Therapeutic | — | $125.59 | — | $0 | 2 | 2009-05-08 |
| CV THERAPEUTICS INC (CVTX) Delisted | Chairman & CEO | 490,432 | — | — | -$9.54M | 25 | 2009-04-17 |
Recent Filings · Page 3 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-08 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2018-03-28 | BOLD | Sell (S) | −48,000 | -$1.39M | EDGAR |
| 2017-12-26 | BOLD | Sell (S) | −18,000 | -$555.8K | EDGAR |
| 2017-10-10 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2017-09-29 | BOLD | Sell (S) | −11,000 | -$311.9K | EDGAR |
| 2017-09-26 | BOLD | Sell (S) | −18,000 | -$509.7K | EDGAR |
| 2017-06-28 | BOLD | Sell (S) | −15,000 | -$296.7K | EDGAR |
| 2016-08-25 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2016-07-25 | BOLD | Conv (C) | +24,633 | $0 | EDGAR |
| 2015-06-30 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.